Dumbbell Aptamer Sensor Based on Dual Biomarkers for Early Detection of Alzheimer's Disease.

Finding a timely, sensitive, and noninvasive detection method has become an urgent need for asymptomatic early diagnosis of Alzheimer's disease (AD). MicroRNA-193b (miR-193b) and Aβ42 oligomers (AβO42) in neurogenic exosomes were confirmed to reflect pathological changes in the AD early stage. The combination of two biomarkers is promising for the earlier detection of AD. In this study, a detection system based on the principle of the entropy-driven strand displacement reaction (ESDR) was developed, including a dumbbell detection probe (H), an indicator probe (R), and graphene oxide (GO). In the detection system, the two hairpins of H were opened by the interaction of miR-193b (T1) and AβO42 (T2) with the aptamer. Then R hybridized with H and began to displace T, initiating the next round of ESDR to achieve sensitive detection of T. GO specifically adsorbed free R and quenched the fluorescence, further reducing the intensity of the background signal. Both of these points provided the system with a more sensitive analytical performance. The detection limit of miR-193b was 77 pM and the detection limit of AβO42 was 53 pM. This sensor detected the change of "one increase (AβO42) and one decrease (miR-193b)" in the exosome sample. Additionally, results showed that this detection system could distinguish the model of early AD from the non-AD control, which was sufficient for earlier and more sensitive detection of AD. This strategy has strong specificity, high sensitivity, and easy operation, which provides broad prospects for the early diagnosis of AD.

[1]  J. Quinn,et al.  Blood extracellular vesicles carrying synaptic function‐ and brain‐related proteins as potential biomarkers for Alzheimer's disease , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[2]  M. Cubizolles,et al.  Development of an Innovative Quantification Assay Based on Aptamer Sandwich and Isothermal Dumbbell Exponential Amplification. , 2022, Analytical chemistry.

[3]  G. Zheng,et al.  Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota. , 2021, ACS applied materials & interfaces.

[4]  Keun-A Chang,et al.  Brain-Derived Exosomal Proteins as Effective Biomarkers for Alzheimer’s Disease: A Systematic Review and Meta-Analysis , 2021, Biomolecules.

[5]  Y. Chernoff,et al.  Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins , 2021, Prion.

[6]  H. P. Karki,et al.  Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease , 2021, Journal of Nanobiotechnology.

[7]  M. Sabbagh,et al.  Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021 , 2021, The Journal of Prevention of Alzheimer's Disease.

[8]  Anonymous,et al.  2021 Alzheimer's disease facts and figures , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[9]  Youngkwan Lee,et al.  Hierarchical and ultra-sensitive amyloid beta oligomer sensor for practical applications , 2020 .

[10]  R. He,et al.  A homogeneous DNA nanosphere for fluorescence detection of microRNAs with high-ordered aggregation enhanced emission and enzyme-free cascade amplification , 2020 .

[11]  Jiashu Sun,et al.  Thermophoretic Detection of Exosomal microRNAs by NanoFlares. , 2020, Journal of the American Chemical Society.

[12]  R. Yuan,et al.  Polymerization nicking-triggered LAMP cascades enable exceptional signal amplification for aptamer-based label-free detection of trace proteins in human serum. , 2020, Analytica chimica acta.

[13]  Philip S. Insel,et al.  Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease , 2019, EMBO molecular medicine.

[14]  J. Jia,et al.  Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid , 2019, Alzheimer's & Dementia.

[15]  Yuanyuan Deng,et al.  Identification and Application of an Aptamer Targeting Papillary Thyroid Carcinoma Using Tissue-SELEX. , 2019, Analytical chemistry.

[16]  J. Wiltfang,et al.  Aβ and tau structure-based biomarkers for a blood- and CSF-based two-step recruitment strategy to identify patients with dementia due to Alzheimer's disease , 2019, Alzheimer's & dementia.

[17]  Yixiang Duan,et al.  A Facile, Label-Free, and Universal Biosensor Platform Based on Target-Induced Graphene Oxide Constrained DNA Dissociation Coupling with Improved Strand Displacement Amplification. , 2018, ACS sensors.

[18]  Weiran Ye,et al.  A sensitive detection assay based on signal amplification technology for Alzheimer's disease's early biomarker in exosome. , 2018, Analytica chimica acta.

[19]  Nam-Trung Nguyen,et al.  Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles. , 2018, Small.

[20]  C. Culbertson,et al.  Effects of storage temperature on airway exosome integrity for diagnostic and functional analyses , 2017, Journal of extracellular vesicles.

[21]  Stefania Minniti,et al.  Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes. , 2016, Biochimica et biophysica acta.

[22]  R. Petersen,et al.  Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study , 2015, Alzheimer's & Dementia.

[23]  J. Kang,et al.  Magnetic bead droplet immunoassay of oligomer amyloid β for the diagnosis of Alzheimer's disease using micro-pillars to enhance the stability of the oil-water interface. , 2015, Biosensors & bioelectronics.

[24]  Cuichen Wu,et al.  A Nonenzymatic Hairpin DNA Cascade Reaction Provides High Signal Gain of mRNA Imaging inside Live Cells , 2015, Journal of the American Chemical Society.

[25]  R. Nieuwland,et al.  Handling and storage of human body fluids for analysis of extracellular vesicles , 2015, Journal of extracellular vesicles.

[26]  Pei-Chang Wang,et al.  MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease. , 2014, Molecular medicine reports.

[27]  Yue-Yang Zhao,et al.  Effects of Aluminium on β-Amyloid (1–42) and Secretases (APP-Cleaving Enzymes) in Rat Brain , 2014, Neurochemical Research.

[28]  Juewen Liu,et al.  Mechanisms of DNA sensing on graphene oxide. , 2013, Analytical chemistry.

[29]  K. Ikebukuro,et al.  Selection of DNA aptamers that recognize α-synuclein oligomers using a competitive screening method. , 2012, Analytical chemistry.

[30]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[31]  V. Maheshwari,et al.  Adsorption and desorption of DNA on graphene oxide studied by fluorescently labeled oligonucleotides. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[32]  Jiaxing Huang,et al.  Visualizing graphene based sheets by fluorescence quenching microscopy. , 2009, Journal of the American Chemical Society.

[33]  Yun Xu,et al.  Alteration of Aβ metabolism-related molecules in predementia induced by AlCl3 and d-galactose , 2009, AGE.